Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

Last Close
Dec 05 04:00PM ET
Dollar change
Percentage change
Index- P/E- EPS (ttm)-17.93 Insider Own34.41% Shs Outstand20.34M Perf Week5.68%
Market Cap385.85M Forward P/E- EPS next Y-3.25 Insider Trans-2.79% Shs Float13.34M Perf Month13.05%
Income-74.77M PEG- EPS next Q-0.72 Inst Own17.42% Short Float / Ratio3.05% / 10.13 Perf Quarter-31.52%
Sales0.00M P/S- EPS this Y83.19% Inst Trans-9.33% Short Interest0.41M Perf Half Y-22.57%
Book/sh34.88 P/B0.54 EPS next Y-3.75% ROA-39.35% Target Price51.50 Perf Year30.83%
Cash/sh7.49 P/C2.53 EPS next 5Y- ROE-41.64% 52W Range8.90 - 32.90 Perf YTD85.98%
Dividend15.12 P/FCF- EPS past 5Y- ROI-50.23% 52W High-42.34% Beta2.25
Dividend %79.69% Quick Ratio15.41 Sales past 5Y0.00% Gross Margin- 52W Low113.15% ATR1.67
Employees129 Current Ratio15.41 Sales Q/Q- Oper. Margin0.00% RSI (14)53.34 Volatility7.80% 9.59%
OptionableNo Debt/Eq0.01 EPS Q/Q20.65% Profit Margin- Rel Volume1.92 Prev Close19.00
ShortableYes LT Debt/Eq0.00 Earnings- Payout- Avg Volume40.12K Price18.97
Recom1.00 SMA209.53% SMA50-7.39% SMA200-22.20% Volume76,962 Change-0.16%
Date Action Analyst Rating Change Price Target Change
Dec-04-23Resumed H.C. Wainwright Buy $48
Nov-17-23Initiated Truist Buy $43
Oct-31-23Initiated Guggenheim Buy $50
Oct-25-23Initiated Piper Sandler Overweight $65
Oct-20-22Initiated H.C. Wainwright Buy $18
Jul-05-22Downgrade Morgan Stanley Overweight → Equal-Weight $20 → $8
Nov-01-23 08:00AM
Oct-26-23 09:02PM
Oct-19-23 05:37PM
Oct-17-23 05:47PM
Oct-06-23 05:09PM
08:30AM Loading…
Oct-04-23 08:30AM
Jun-22-23 07:30AM
May-26-23 07:00AM
May-20-23 08:18AM
Feb-16-23 03:10PM
Dec-25-22 09:25AM
Nov-22-22 07:00AM
Nov-10-22 07:00AM
Nov-07-22 07:00AM
11:28AM Loading…
Oct-21-22 11:28AM
Oct-20-22 02:27PM
Oct-17-22 07:00AM
Oct-04-22 07:00AM
Sep-21-22 07:00AM
Sep-06-22 07:00AM
Aug-15-22 07:00AM
Jul-18-22 09:47AM
Jun-30-22 07:00AM
Jun-07-22 04:01PM
Jun-01-22 07:00AM
May-31-22 07:00AM
04:01PM Loading…
May-17-22 04:01PM
May-12-22 04:01PM
May-02-22 07:00AM
Apr-28-22 11:45AM
Apr-06-22 04:01PM
Mar-22-22 04:01PM
Mar-17-22 04:01PM
Feb-11-22 07:00AM
Feb-08-22 01:32PM
Jan-31-22 09:38AM
Jan-06-22 07:00AM
Jan-04-22 07:00AM
Dec-20-21 07:00AM
Dec-14-21 07:00AM
Nov-30-21 07:00AM
Nov-12-21 07:00AM
Nov-08-21 07:00AM
Nov-04-21 06:00AM
Oct-29-21 07:00AM
Oct-28-21 04:36PM
Sep-02-21 07:00AM
Aug-12-21 07:00AM
Aug-10-21 08:10AM
Jun-14-21 04:01PM
Jun-03-21 07:00AM
May-11-21 04:01PM
May-06-21 09:53PM
Tourmaline Bio, Inc. is a late-stage clinical biotechnology company, which engages in the development of medicines for patients with life-altering immune diseases. The firm offers TOUR006, an anti-IL-6 antibody that exhibits differentiated properties including high binding affinity to IL-6 and a naturally long half-life. It also plans to develop TOUR006 in thyroid eye disease and atherosclerotic cardiovascular disease. The company was founded by Sandeep Kulkarni on September 17, 2021 and is headquartered in New York, NY.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Kulkarni Sandeep ChidambarCEONov 17Buy16.994,00067,960729,735Nov 20 06:15 PM
Thiara ParvinderDirectorNov 17Buy17.311,00017,31083,782Nov 20 06:14 PM
Castelein CaleyDirectorOct 27Buy14.5515,800229,890516,519Oct 27 05:43 PM
Kulkarni Sandeep ChidambarCEOOct 26Buy12.255,00061,250725,735Oct 26 05:34 PM
Castelein CaleyDirectorOct 25Buy12.074,20050,694500,719Oct 27 05:43 PM
Thiara ParvinderDirectorOct 25Buy12.122,00024,24082,782Oct 26 04:46 PM
KANTOFF AARONDirectorOct 24Buy11.867,50088,95045,391Oct 26 05:00 PM
Thiara ParvinderDirectorOct 24Buy10.665,00053,30080,782Oct 26 04:46 PM
Kulkarni Sandeep ChidambarCEOOct 24Buy10.684,65049,662720,735Oct 26 05:34 PM
Ildstad SuzanneDirectorJun 14Sale2.4912,94232,2443,771,392Jun 14 06:58 PM
Ildstad SuzanneDirectorJun 13Sale2.5614,20836,3383,784,334Jun 14 06:58 PM
Ildstad SuzanneDirectorJun 12Sale2.5916,87043,7253,798,542Jun 14 06:58 PM
Ildstad SuzanneDirectorJun 09Sale2.4625,41962,6373,815,412Jun 09 05:41 PM
Ildstad SuzanneDirectorJun 08Sale2.4840,642100,7723,840,831Jun 09 05:41 PM
Ildstad SuzanneDirectorJun 07Sale2.3975,001179,0953,881,473Jun 09 05:41 PM
Ildstad SuzanneDirectorJun 06Sale2.5325,54964,5962,756,474Jun 07 06:24 PM
Ildstad SuzanneDirectorJun 05Sale2.527,84119,7552,782,023Jun 07 06:24 PM
Ildstad SuzanneDirectorJun 02Sale2.5015,81839,6162,789,864Jun 05 04:21 PM
Ildstad SuzanneDirectorJun 01Sale2.5615,71340,1772,805,682Jun 05 04:21 PM
Ildstad SuzanneDirectorApr 21Sale2.3515,00435,2312,821,395Apr 25 05:50 PM
Ildstad SuzanneDirectorApr 20Sale2.3346,990109,3132,836,399Apr 21 07:57 AM
Ildstad SuzanneDirectorApr 19Sale2.1621,75347,0562,883,389Apr 21 07:57 AM
Ildstad SuzanneDirectorApr 18Sale2.1549,211105,8042,905,142Apr 19 09:22 AM
Ildstad SuzanneDirectorApr 17Sale2.1499,771213,5302,954,353Apr 19 09:22 AM
Ildstad SuzanneDirectorMar 17Sale2.0610,43621,5433,054,124Mar 20 04:36 PM
Ildstad SuzanneDirectorMar 03Sale2.066,80613,9923,064,560Mar 07 04:58 PM
Ildstad SuzanneDirectorMar 01Sale2.0529593,071,366Mar 02 05:26 PM
Ildstad SuzanneDirectorFeb 21Sale2.053,5007,1853,071,395Feb 23 05:01 PM
Ildstad SuzanneDirectorFeb 17Sale2.053,6127,4063,074,895Feb 21 11:16 AM
Ildstad SuzanneDirectorFeb 16Sale2.062,9396,0403,078,507Feb 21 11:16 AM